Plymouth Meeting alternative opioid maker raises $3.9M

Tiny Madrigal’s stock is soaring as it advances an experimental drug targeting NASH (Photo courtesy of

A Montgomery County biopharmaceutical company taking on the opioid addiction epidemic has raised $3.9 million in an equity financing.

The private stock sale by Mirata Pharmaceuticals of Plymouth Meeting, Pa., was disclosed in a filing the company made earlier this month with the Securities and Exchange Commission, writes John George at

[uam_ad id=”54865″]

The company was founded in 2017 by a group that included Maurits Geerlings, the president and CEO of Formula Pharmaceuticals in Berwyn, Pa.

On its Facebook page, Mirata states it is “developing new options for patients and physicians that provide the powerful pain relieving benefits of opioids, but without the significant side effects.”

To read the full article, click here.

[uam_ad id=”54875″]

Stay Connected, Stay Informed

Subscribe for great stories in your community!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.